Alzheimer's Disease

A brief assessment in primary care can help identify patients most at risk

Screening, administration, and eligibility concerns remain

Findings may help identify Alzheimer's disease long before cognitive changes emerge

But risks associated with anti-amyloid agent lecanemab still loom

Risks of ARIA do not appear to preclude traditional approval, agency says

Relationships not seen in people without amyloid plaques

But this didn't seem to translate into Alzheimer's disease-related neurodegeneration

Also in TTHealthWatch: promoting "goals of care" discussions

Sandeep Jauhar, MD, PhD, on his career and wrestling with his father's dementia

Finding challenges previous assumptions about disease

Boxed warning on increased mortality risk in elderly patients remains for brexpiprazole

Health news and commentary from around the Web gathered by MedPage Today staff

Many on both sides of the aisle expressed concerns

How tech can help make a better future for patients